Adult Langerhans Cell Histiocytosis Mimicking Miliary Tuberculosis: A Multimodality Imaging Case Report

Langerhans cell histiocytosis (LCH), historically known as histiocytosis X, is a rare disorder that can present as single-system or multisystem disease. In adults, it predominantly occurs in current or former smokers, who typically have upper- and mid-lung micronodules, nodules, or cavitated nodules and cysts. In multisystem disease, bone involvement is a recognized extrapulmonary manifestation that can lead to an initial misdiagnosis of infection or metastatic disease. This case describes a 62-year-old woman presenting with chronic lower back pain. Imaging initially revealed a lytic vertebral lesion and pulmonary micronodules and nodules with a miliary distribution, identified during an oncological workup using whole-body fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) and thoracoabdominal CT. Extensive microbiological investigations led to invasive diagnostic procedures, including bronchoalveolar lavage, transbronchial biopsy, and vertebral biopsy, which were initially negative. Miliary tuberculosis (TB) was initially suspected, and empirical four-drug antituberculous treatment was initiated in May 2022. After approximately six weeks, no significant radiographic improvement was observed. Follow-up FDG PET/CT in July 2022 demonstrated a mixed metabolic response, including a new FDG-avid vertebral lesion. Antituberculous treatment was discontinued after approximately 11 weeks because of the absence of a favorable overall imaging response and negative mycobacterial cultures. Subsequent evolution of the pulmonary nodules, with cavitation and cyst formation, prompted reconsideration of the diagnosis. Reassessment of the pulmonary biopsy showed numerous CD1a- and S100-positive cells, and molecular testing later identified a BRAF p.V600E/D alteration, further supporting the diagnosis of LCH. Following smoking cessation, subsequent imaging demonstrated marked improvement in the pulmonary abnormalities and metabolic normalization of the previously active osseous lesions. This case illustrates the value of serial CT imaging and FDG PET/CT in redirecting the diagnostic approach when adult LCH initially mimics miliary TB.

Authors

Institutions

Publication Details

Journal
Cureus
Published
2026-11-16
DOI
https://doi.org/10.7759/cureus.119723
Primary Topic
Histiocytic Disorders and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Adult Langerhans Cell Histiocytosis Mimicking Miliary Tuberculosis: A Multimodality Imaging Case Report

Pascale Bohy, Dulcis I Burundi
2 links
Cureus
Histiocytic Disorders and Treatments
article

Adult Langerhans Cell Histiocytosis Mimicking Miliary Tuberculosis: A Multimodality Imaging Case Report

Pascale Bohy, Dulcis I Burundi
article en

Abstract

Langerhans cell histiocytosis (LCH), historically known as histiocytosis X, is a rare disorder that can present as single-system or multisystem disease. In adults, it predominantly occurs in current or former smokers, who typically have upper- and mid-lung micronodules, nodules, or cavitated nodules and cysts. In multisystem disease, bone involvement is a recognized extrapulmonary manifestation that can lead to an initial misdiagnosis of infection or metastatic disease. This case describes a 62-year-old woman presenting with chronic lower back pain. Imaging initially revealed a lytic vertebral lesion and pulmonary micronodules and nodules with a miliary distribution, identified during an oncological workup using whole-body fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) and thoracoabdominal CT. Extensive microbiological investigations led to invasive diagnostic procedures, including bronchoalveolar lavage, transbronchial biopsy, and vertebral biopsy, which were initially negative. Miliary tuberculosis (TB) was initially suspected, and empirical four-drug antituberculous treatment was initiated in May 2022. After approximately six weeks, no significant radiographic improvement was observed. Follow-up FDG PET/CT in July 2022 demonstrated a mixed metabolic response, including a new FDG-avid vertebral lesion. Antituberculous treatment was discontinued after approximately 11 weeks because of the absence of a favorable overall imaging response and negative mycobacterial cultures. Subsequent evolution of the pulmonary nodules, with cavitation and cyst formation, prompted reconsideration of the diagnosis. Reassessment of the pulmonary biopsy showed numerous CD1a- and S100-positive cells, and molecular testing later identified a BRAF p.V600E/D alteration, further supporting the diagnosis of LCH. Following smoking cessation, subsequent imaging demonstrated marked improvement in the pulmonary abnormalities and metabolic normalization of the previously active osseous lesions. This case illustrates the value of serial CT imaging and FDG PET/CT in redirecting the diagnostic approach when adult LCH initially mimics miliary TB.

Cureus
Erasmus Hospital (BE)
Good health and well-being
Histiocytic Disorders and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon